Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1420 ARTÍCULOS , VIENDO DEL 1231 AL 1245

Targeting brain connectivity in Alzheimer's disease with repurposed drugs

Pini L, Imbimbo BP, Griffa A, Allali G, Pomara N.

Ageing Res Rev. 2026 Jan;114:103001. doi: 10.1016/j.arr.2025.103001. Epub 2025 Dec 18.

Protein and peptide based nanotherapeutics for the management of Alzheimer's disease: Current insights and future directions

Das SK, Bashir B, Kolekar KA, Harish V, Patle D, Vishwas S, Mittal N, Jha SK, Kumar P, Gupta G, Dureja H, Dua K, Chang D, Kuppusamy G, Singh SK.

Ageing Res Rev. 2026 Jan;114:103000. doi: 10.1016/j.arr.2025.103000. Epub 2025 Dec 18.

Integrative Multiomics Insights into the Genetic and Epigenetic Architecture of Alzheimer's Disease

Mishra AK, Jain S.

ACS Chem Neurosci. 2026 Jan 21;17(2):316-334. doi: 10.1021/acschemneuro.5c00750. Epub 2025 Dec 21.

PACAP: A promising disease-modifying target for Alzheimer's disease

Basri R, Al-Kuraishy HM, Fawzy MN, Alruwaili M, Batiha GE.

Life Sci. 2026 Feb 1;386:124176. doi: 10.1016/j.lfs.2025.124176. Epub 2025 Dec 24.

Emerging therapeutics targeting the PI3K/Akt/GSK-3β in calcium dysregulation in Alzheimer's disease

Soni S, Kaur G.

Cell Calcium. 2026 Jan;133:103107. doi: 10.1016/j.ceca.2025.103107. Epub 2025 Dec 23.

Exercise impact on IRE1α signaling: Novel insights into Alzheimer's disease prevention and treatment

Haixia T, Bo X.

Biochem Biophys Res Commun. 2026 Jan 25;797:153156. doi: 10.1016/j.bbrc.2025.153156. Epub 2025 Dec 18.

Metal-Organic Frameworks as Interfacial Platforms for Early Diagnosis of Alzheimer's Disease

Thokal G, Garg M, Bathinapatla A, Farale H, Kanchi S.

Langmuir. 2026 Jan 13;42(1):32-56. doi: 10.1021/acs.langmuir.5c04804. Epub 2025 Dec 29.

Proposed unified model of late-onset Alzheimer's disease: Chronic astrocytic and neuronal bioenergetic failure

Garrahy JP.

J Alzheimers Dis. 2026 Feb;109(3):1117-1136. doi: 10.1177/13872877251404970. Epub 2025 Dec 29.

Precision therapeutic strategies for Alzheimer's disease: Amyloid β-targeted foundations and multimodal next-generation approaches

Zafar I, Khan MS, Jamal A, Shafiq S, Bahwerth FS, Khan NU.

Mol Cell Neurosci. 2026 Mar;136:104070. doi: 10.1016/j.mcn.2025.104070. Epub 2025 Dec 30.

Natural glycosides as multi-target neuroprotective agents in Alzheimer's disease: Bridging mechanistic insights and translational potential

Zhou M, Tang S, Zhang Y, Fu G, Yu W, Wang S, Cheng S, Song Z.

Phytomedicine. 2026 Jan;150:157738. doi: 10.1016/j.phymed.2025.157738. Epub 2025 Dec 23.

Alzheimer's disease: unraveling role of xanthone derivatives and nanocarriers

Suhaili INA, Yow HY, Mah SH, Zaman Huri H, Tan SLJ.

Naunyn Schmiedebergs Arch Pharmacol. 2026 Jan;399(1):1-17. doi: 10.1007/s00210-025-04446-8. Epub 2025 Aug 1.

Hippocampal neural stem cells in Alzheimer's disease: bridging neurogenesis, extracellular vesicles, and multimodal therapeutic paradigms

Li R, Xiong W, Sun C.

Int J Neurosci. 2026 Mar;136(3):380-400. doi: 10.1080/00207454.2025.2540989. Epub 2025 Aug 8.

Expanding the scope of olfactory evaluation in Alzheimer's disease and related dementias (ADRD): A narrative review of the role for odor memory and recognition in AD/ADRD

Saak TM, Tervo JP, Motter JN, Overdevest JB.

J Alzheimers Dis. 2026 Mar;110(1_suppl):S68-S82. doi: 10.1177/13872877251389113. Epub 2025 Oct 27.

Amyloid-β as a cytokine-like somnogen: Rethinking its role in sleep homeostasis and Alzheimer's disease

Fernandez FX, Grandner MA.

J Alzheimers Dis. 2026 Jan;109(1):70-83. doi: 10.1177/13872877251392186. Epub 2025 Nov 5.

Genetic and functional dynamics of Butyrylcholinesterase in Alzheimer's disease: From mechanisms to clinical relevance

Prešern U, Goličnik M, Bavec A.

Chem Biol Interact. 2026 Jan 5;423:111809. doi: 10.1016/j.cbi.2025.111809. Epub 2025 Nov 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias